pyrroles has been researched along with Peripheral Arterial Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcazar, C; Ding, S; Hou, L; Huang, NF; Joshi, P; Kawamura, M; Kim, M; Shrager, J; Strassberg, Z; Tang, S; Woo, YJ; Yang, G | 1 |
| Boekholdt, SM; Fayyad, R; Hovingh, GK; Laskey, R; Pedersen, TR; Stoekenbroek, RM; Tikkanen, MJ | 1 |
| Bonaca, MP; Creager, MA | 1 |
| Bando, YK; Monji, A; Morimoto, Y; Murohara, T; Shigeta, T | 1 |
| Antovic, A; Antovic, J; Bröijersen, A; Egberg, N; He, S; Jörneskog, G; Mobarrez, F; Wallén, H; Wiklund, B | 1 |
| Lip, GY; Montoro-García, S; Shantsila, E | 1 |
| Koppensteiner, R; Spring, S; van der Loo, B | 1 |
| Antovic, J; Bröijersen, A; Egberg, N; Jörneskog, G; Mobarrez, F; Wallén, H | 1 |
| Buszman, PE; Buszman, PP; Kiesz, RS; Konkolewska, MD; Martin, JL; Radvany, MG; Szymanski, R; Wiernek, BK; Wiernek, SL | 1 |
1 review(s) available for pyrroles and Peripheral Arterial Disease
| Article | Year |
|---|---|
Pharmacological treatment and current management of peripheral artery disease.
Topics: Atorvastatin; Exercise; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrroles; Simvastatin; Smoking Cessation; Treatment Outcome | 2015 |
4 trial(s) available for pyrroles and Peripheral Arterial Disease
| Article | Year |
|---|---|
High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease.
Topics: Aged; Atorvastatin; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Netherlands; Peripheral Arterial Disease; Prospective Studies; Pyrroles; Scandinavian and Nordic Countries; Simvastatin | 2015 |
Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.
Topics: Aged; Atorvastatin; Blood Platelets; Cell-Derived Microparticles; Cross-Over Studies; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Integrin beta3; Male; Middle Aged; P-Selectin; Peripheral Arterial Disease; Pyrroles; Thrombin; Thromboplastin | 2011 |
High-dose atorvastatin treatment in patients with peripheral arterial disease: effects on platelet aggregation, blood rheology and plasma homocysteine.
Topics: Aged; Atorvastatin; Female; Hemorheology; Heptanoic Acids; Homocysteine; Humans; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation; Prospective Studies; Pyrroles | 2011 |
Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study.
Topics: Aged; Antigens, CD; Atorvastatin; Biomarkers; Cadherins; Cell-Derived Microparticles; Cross-Over Studies; Double-Blind Method; Endothelial Cells; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Peripheral Arterial Disease; Placebos; Pyrroles; Sweden; Thromboplastin; Time Factors; Treatment Outcome | 2012 |
4 other study(ies) available for pyrroles and Peripheral Arterial Disease
| Article | Year |
|---|---|
Small Molecule Derived From Carboxyethylpyrrole Protein Adducts Promotes Angiogenesis in a Mouse Model of Peripheral Arterial Disease.
Topics: Animals; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Female; Hindlimb; Humans; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Peripheral Arterial Disease; Pyrroles | 2018 |
Atorvastatin prevents ischemic limb loss in type 2 diabetes: role of p53.
Topics: Animals; Atorvastatin; Blotting, Western; Cells, Cultured; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Extremities; Heart; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Ischemia; Male; Mice; Myoblasts; Peripheral Arterial Disease; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Pyrroles; Tumor Suppressor Protein p53; Ubiquitin; Wound Healing | 2011 |
Atorvastatin and its collateral effects on microparticles.
Topics: Atorvastatin; Blood Platelets; Cell-Derived Microparticles; Female; Heptanoic Acids; Humans; Male; Peripheral Arterial Disease; Pyrroles | 2011 |
Long-term results of plaque excision combined with aggressive pharmacotherapy in high-risk patients with advanced peripheral artery disease (SAVE a LEG registry).
Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Aspirin; Atherectomy; Atorvastatin; Cardiovascular Agents; Clopidogrel; Combined Modality Therapy; Critical Illness; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrroles; Recurrence; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Ticlopidine; Time Factors; Treatment Outcome | 2013 |